# C_2005119EN.01000901.xml

| 20.5.2005 | EN | Official Journal of the European Union | C 119/9 |
| --- | --- | --- | --- |

20.5.2005

EN

Official Journal of the European Union

C 119/9

---

Prior notification of a concentration

(Case COMP/M.3816 — Apax/Mölnlycke)

(2005/C 119/06)

(Text with EEA relevance)

| 1. | On 10 May 2005, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Apax Europe V (‘Apax Europe V’, Guernsey) belonging to the group Apax (‘Apax’) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Mölnlycke Health Care AB (‘Mölnlycke’, Sweden) by way of purchase of shares. |
| --- | --- |

1.

On 10 May 2005, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Apax Europe V (‘Apax Europe V’, Guernsey) belonging to the group Apax (‘Apax’) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Mölnlycke Health Care AB (‘Mölnlycke’, Sweden) by way of purchase of shares.

1

| 2. | The business activities of the undertakings concerned are:






  — | for Apax Europe V: Investment fund, active in the manufacture and sale of surgical gloves through Regent Medical Limited (‘Regent’) and of medical products, including wound care products, through Medlock Medical Limited (‘Medlock’); |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for Apax Europe V: Investment fund, active in the manufacture and sale of surgical gloves through Regent Medical Limited (‘Regent’) and of medical products, including wound care products, through Medlock Medical Limited (‘Medlock’);

| — | for Mölnlycke: manufacture and sale of single use surgical products and wound care products. |
| --- | --- |

—

for Mölnlycke: manufacture and sale of single use surgical products and wound care products.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No (32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.3816 — Apax/Mölnlycke, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition, |
| Merger Registry |
| J-70 |
| B-1049 Brussels |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (No (32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.3816 — Apax/Mölnlycke, to the following address:

European Commission

Directorate-General for Competition,

Merger Registry

J-70

B-1049 Brussels

---

(1)  OJ L 24, 29.1.2004, p. 1.

1

---